Sunday, 14 June 2026European Markets

#NVIDIA BioNeMo

3 articles

Novo Nordisk Outsources Parkinson's Programs to AI Partner as Stock Surges 24.9%

European Pharma

Novo Nordisk Outsources Parkinson's Programs to AI Partner as Stock Surges 24.9%

Salvado•Jun 9, 2026

Novo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House Biology

European Pharma

Novo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House Biology

Salvado•May 31, 2026

Novo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal Unit

European Pharma

Novo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal Unit

Salvado•May 16, 2026